top of page
EUD-GK-91in NSCLC
-
EUD-GK-91 has succesfully reached PoC in NSCLC Tumour Cells
-
EUD-GK-91 shows a preferential and significant inhibition of the gatekeeper resistant mutation
-
EUD-GK-91 has a good selectivity profile with low effect on normal cells
-
Eudendron has developed novel molecular designs to generate compounds successfully inhibiting kinase mutated forms
-
EUD-GK-91 is a novel compound designed and prepared by Eudendron to provide an effective and promising answer to drug resistance in NSCLC treatment
bottom of page